These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 19515414

  • 1. GLP-1 receptor agonists for type 2 diabetes.
    De Block CE, Van Gaal LF.
    Lancet; 2009 Jul 04; 374(9683):4-6. PubMed ID: 19515414
    [No Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults.
    Tzefos M, Harris K, Brackett A.
    Ann Pharmacother; 2012 Jan 04; 46(1):68-78. PubMed ID: 22232377
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Emerging GLP-1 receptor agonists.
    Lund A, Knop FK, Vilsbøll T.
    Expert Opin Emerg Drugs; 2011 Dec 04; 16(4):607-18. PubMed ID: 21905764
    [Abstract] [Full Text] [Related]

  • 10. Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in type 2 diabetes.
    Ross SA, Ballantine J.
    Curr Med Res Opin; 2013 Dec 04; 29(12):1617-26. PubMed ID: 23971789
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials.
    Monami M, Dicembrini I, Nardini C, Fiordelli I, Mannucci E.
    Diabetes Res Clin Pract; 2014 Feb 04; 103(2):269-75. PubMed ID: 24485345
    [Abstract] [Full Text] [Related]

  • 13. Liraglutide in oral antidiabetic drug combination therapy.
    Garber AJ.
    Diabetes Obes Metab; 2012 Apr 04; 14 Suppl 2():13-9. PubMed ID: 22405265
    [Abstract] [Full Text] [Related]

  • 14. Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
    Hansen KB, Knop FK, Holst JJ, Vilsbøll T.
    Int J Clin Pract; 2009 Aug 04; 63(8):1154-60. PubMed ID: 19624785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Liraglutide for type 2 diabetes?
    Drug Ther Bull; 2010 May 04; 48(5):50-3. PubMed ID: 20447980
    [Abstract] [Full Text] [Related]

  • 18. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.
    Meier JJ.
    Nat Rev Endocrinol; 2012 Dec 04; 8(12):728-42. PubMed ID: 22945360
    [Abstract] [Full Text] [Related]

  • 19. [Protective effects of glucagon-like peptide-1 on beta-cells: preclinical and clinical data].
    Consoli A, Di Biagio R.
    G Ital Cardiol (Rome); 2011 Dec 04; 12(12 Suppl 2):5-9. PubMed ID: 22158421
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders.
    Wroge J, Williams NT.
    Ann Pharmacother; 2016 Dec 04; 50(12):1041-1050. PubMed ID: 27531946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.